Calando Pharmaceuticals

Calando Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies using its patented and proprietary cyclodextrin-based polymer technology to create nanoparticle drug formulations. Calando's initial focus was on applying targeted siRNA and small molecule therapies in oncology clinical settings; however, these technologies are not limited to these categories of molecules and are applicable to a very broad range of therapeutic entities and diseases.